Literature DB >> 27241035

ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

S Zouine1,2, F Marnissi3, N Otmani4, M Bennani Othmani4, M El Wafi5,6, K Kojok7, Y Zaid7, N Tahiri Jouti8, N Habti5,6.   

Abstract

The association between blood groups ABO and different types of diseases was established in several previous studies. Our aim was to seek the possible association between the ABO blood group and breast cancer-associated prognostic factors. The Chi-squared analytic test was used to compare phenotypic ABO distribution among Moroccan blood donors and 442 cases of women suffering from breast carcinoma with archived files in Maternity Ward of University Hospital C.H.U Ibn Rochd between 2008 and 2011. High incidence of breast carcinoma was observed in blood type B patients (p < 0.05). Blood type B was associated with breast carcinomas overexpressing human epidermal growth factor receptor HER2 (p < 0.05) and high risk of cancer at age over 70 years (p < 0.001). Blood type A was associated with high risk of cancer among women younger than 35 years old. Blood type A and AB were associated with high incidence of lymph node metastasis (p < 0.05). Multivariate analysis has shown correlation between O blood type and estrogen receptor-positive tumor. Patients with blood group A, B, and AB were more likely to develop aggressive breast carcinoma. Further follow-up studies are necessary to clarify the role of ABH antigens in the progression of breast carcinoma.

Entities:  

Keywords:  ABO blood group; Age at diagnosis; Breast carcinoma; Estrogen receptor; Human epidermal growth factor receptor 2; Lymph node metastasis

Mesh:

Substances:

Year:  2016        PMID: 27241035     DOI: 10.1007/s12032-016-0784-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  55 in total

Review 1.  ABO blood group and cancer.

Authors:  Simona Iodice; Patrick Maisonneuve; Edoardo Botteri; Maria Teresa Sandri; Albert B Lowenfels
Journal:  Eur J Cancer       Date:  2010-12       Impact factor: 9.162

2.  Polymorphisms of Lewis and Secretor genes are related to breast cancer and metastasis in axillary lymph nodes.

Authors:  Debora Barreto Teresa; Raquel Alves Santos; Catarina Satie Takahashi; Helio H Carrara; Haroldo W Moreira; Luis Carlos Mattos; Nicolino Lia-Neto; Leonardo A Cunha; Carmem Lucia Bassi; Edson Garcia Soares; Eduardo Antonio Donadi; Elaine Rodrigues Mello; Christiane Pienna Soares
Journal:  Tumour Biol       Date:  2010-06-01

3.  Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.

Authors:  M Simoneau; H LaRue; T O Aboulkassim; F Meyer; L Moore; Y Fradet
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

4.  ABO blood group and risk of renal cell cancer.

Authors:  Hee-Kyung Joh; Eunyoung Cho; Toni K Choueiri
Journal:  Cancer Epidemiol       Date:  2012-07-26       Impact factor: 2.984

5.  [Pancreatic cancer and ABO blood types: a study of cases and controls].

Authors:  J Vioque; A M Walker
Journal:  Med Clin (Barc)       Date:  1991-05-25       Impact factor: 1.725

Review 6.  von Willebrand factor and cancer: a renewed interest.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti; Giuseppe Lippi
Journal:  Thromb Res       Date:  2013-02-08       Impact factor: 3.944

Review 7.  The histo-blood group ABO system and tissue transplantation.

Authors:  T Eastlund
Journal:  Transfusion       Date:  1998-10       Impact factor: 3.157

8.  Blood group as a prognostic indicator in breast cancer.

Authors:  P J Holdsworth; J Thorogood; E A Benson; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

9.  Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.

Authors:  Guillaume Paré; Daniel I Chasman; Mark Kellogg; Robert Y L Zee; Nader Rifai; Sunita Badola; Joseph P Miletich; Paul M Ridker
Journal:  PLoS Genet       Date:  2008-07-04       Impact factor: 5.917

10.  A genome-wide association study identifies protein quantitative trait loci (pQTLs).

Authors:  David Melzer; John R B Perry; Dena Hernandez; Anna-Maria Corsi; Kara Stevens; Ian Rafferty; Fulvio Lauretani; Anna Murray; J Raphael Gibbs; Giuseppe Paolisso; Sajjad Rafiq; Javier Simon-Sanchez; Hana Lango; Sonja Scholz; Michael N Weedon; Sampath Arepalli; Neil Rice; Nicole Washecka; Alison Hurst; Angela Britton; William Henley; Joyce van de Leemput; Rongling Li; Anne B Newman; Greg Tranah; Tamara Harris; Vijay Panicker; Colin Dayan; Amanda Bennett; Mark I McCarthy; Aimo Ruokonen; Marjo-Riitta Jarvelin; Jack Guralnik; Stefania Bandinelli; Timothy M Frayling; Andrew Singleton; Luigi Ferrucci
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

View more
  4 in total

1.  Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society.

Authors:  Sungmin Park; Ku Sang Kim; Jeong-Soo Kim; Wonshik Han; Byeong-Woo Park; Seokwon Lee; Ye Won Jeon; Se Kyung Lee; Jonghan Yu; Jeong Eon Lee; Seok Won Kim; Seok Jin Nam
Journal:  Med Oncol       Date:  2017-05-12       Impact factor: 3.064

2.  Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey.

Authors:  Serkan Akin; Kadri Altundag
Journal:  Med Sci Monit       Date:  2018-07-07

3.  ABO BLOOD GROUP GENOTYPES IN WOMEN WITH BREAST CANCER.

Authors:  Tamara Bezek; Jasna Bingulac-Popović; Dinko Bagatin; Roberta Petlevski; Irena Jukić
Journal:  Acta Clin Croat       Date:  2022-02       Impact factor: 0.780

4.  Blood group A: a risk factor for heart rupture after acute myocardial infarction.

Authors:  Yuan Fu; Mulei Chen; Hao Sun; Zongsheng Guo; Yuanfeng Gao; Xinchun Yang; Kuibao Li; Lefeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.